The global insufflation devices market size was valued at USD 3.15 billion in 2025 and is projected to grow from USD 3.35 billion in 2026 to USD 5.45 billion by 2034, registering a CAGR of 6.27% during the forecast period (2026–2034). North America dominated the insufflation devices market with a share of 39.85% in 2025.
The insufflation devices are medical devices used to introduce gas or liquid into a body cavity to create controlled distension and provide adequate visualization and working space during minimally invasive procedures. Insufflation devices are tracked under HSN Code 9018 (surgical instruments and appliances used in medical or surgical sciences) and SIC Code 3841 (surgical and medical instruments and apparatus).
The insufflation devices market demand is supported by the adoption of minimally invasive surgeries, high laparoscopic and endoscopic procedure volumes, and preference for procedures requiring controlled cavity distension. Hospitals and surgical centers focus on regulating gas flow and pressure during laparoscopic and endoscopic procedures, contributing to the insufflation devices market growth.
• 2025 Market Size: USD 3.15 Billion• 2026 Market Size: USD 3.35 Billion• 2034 Projected Market Size: USD 5.49 Billion• Forecast Period: 2026–2034• Base Year: 2025• Market CAGR (2026–2034): 6.27%
• Largest Regional Market (2025): North America• North America Market Share (2025): 39.85%• Fastest-growing Region: Asia Pacific• Asia Pacific CAGR (2026–2034): 7.93%
By Product Type
• Leading Segment: Insufflation Systems• Market Share in 2025: 48.35%
By Application
• Fastest-growing Segment: Bariatric Surgery• CAGR: 7.15% (2026–2034)
By End Use
• Leading Segment: Hospitals• Market Share in 2025: 61.45%
Download a Free Sample To learn more about this report,
Integration of Smoke Evacuation into Insufflation Systems
The insufflation devices market analysis shows that systems are increasingly combining CO₂ delivery with surgical smoke evacuation in a single device. This setup can remove smoke generated during laparoscopic procedures while maintaining the required abdominal pressure. This integration simplifies operating room equipment and supports cleaner surgical fields.
Adoption of Heated and Humidified CO₂ Insufflation
Insufflation devices are incorporating heated and humidified CO₂ delivery to condition the gas before it enters the abdominal cavity. The approach can help reduce the drying and cooling effects associated with conventional cold and dry gas. This development improves the functionality of insufflation systems during minimally invasive procedures.
Supply chain disruptions are expected to have a moderate impact on the insufflation devices market share, as dependence on precision pressure control components, sensors, electronic systems, motors, sterile tubing, and regulated medical device manufacturing can create procurement delays and higher equipment costs. The market is likely to follow a U-shaped recovery pattern, as disruptions can delay hospital equipment procurement and installation for an extended period before orders, manufacturing, and clinical deployment return toward normal levels through the replacement cycle. The market is expected to grow at a CAGR of 6.27%, but supply chain constraints could approximately lower this by 0.3 percentage points, resulting in short-term growth of around 5.97%. As supply conditions normalize through improved availability of precision components, stronger regional manufacturing, diversified sourcing, and more reliable medical device logistics, insufflation devices market growth is expected to gradually return to 6.27%.
The insufflation devices market forecasts strategic investment activity driven by advanced CO₂ insufflation systems, personalized pressure control, high-flow and low-pressure technologies, integrated smoke evacuation, and the growing adoption of laparoscopic and robotic-assisted surgery.
In October 2025, Spatium Medical closed an extension funding round backed by InnovationQuarter Capital, with participation from Van Herk Ventures, Demcon Innovatiefonds, Erasmus MC, Human Plus, and CEO Willem Mees van der Bijl, to accelerate international expansion of its smart CO₂ insufflator, particularly in the US.
Demand for Stable Pneumoperitoneum during Surgery and Adoption of Intelligent Flow-Control Systems Drives Market
Laparoscopic procedures require consistent intra-abdominal pressure to maintain an adequate surgical workspace and visualization, increasing the demand for stable pneumoperitoneum. Insufflators with automatic pressure monitoring, rapid flow adjustment, and leakage compensation can maintain the target pressure during instrument exchanges and other sources of gas loss, increasing demand for advanced insufflation systems.
The adoption of intelligent flow-control systems is driving the insufflation devices market as surgical teams demand precise regulation of CO₂ flow and intra-abdominal pressure throughout laparoscopic procedures. Demand is increasing for insufflators that can detect pressure changes, compensate for gas leakage, and automatically adjust flow to maintain a stable pneumoperitoneum, supporting consistent visualization and surgical control.
Elevated Carbon Dioxide Consumption Costs and Pressure Calibration Requirements Restrains Market Expansion
Repeated carbon dioxide (CO₂) insufflation can increase gas consumption during minimally invasive surgery, especially in procedures requiring longer operating times. Higher gas use can raise recurring operating expenses for hospitals and surgical centers.
Complex pressure calibration requirements can make it harder to maintain stable gas flow and intra-abdominal pressure during procedures. Regular calibration and performance checks can add maintenance work and affect the availability of surgical insufflators.
Development of Low-Flow Insufflation Systems and Expansion of Equipment Service Contracts Offer Growth Opportunities
Low-flow insufflation devices can maintain stable abdominal insufflation while using less carbon dioxide during laparoscopic surgery. Manufacturers can differentiate these systems through efficient gas delivery and precise control for endoscopic surgery. This creates a product opportunity focused on gas efficiency and operating cost management.
Equipment service contracts can combine preventive maintenance, inspection, and technical support for surgical insufflators. Suppliers can provide scheduled servicing and performance checks for operating room equipment used across different surgical specialties. This creates recurring service revenue beyond initial equipment sales.
Variation in Insufflation Protocols and Incoordination Between Surgical Teams Hinders Growth
Different pressure settings, gas flow practices, and monitoring methods across surgical centers can create variation in carbon dioxide (CO₂) insufflation during procedures. Such differences can affect surgical visualization and make consistent use of pressure control systems more difficult across facilities.
Coordination between surgical and anesthesia teams is important when changes in abdominal insufflation affect intraoperative conditions. Differences in communication about pressure adjustments, gas flow, and patient response can complicate management during endoscopic surgery.
The insufflation systems segment accounted for a share of 48.35% in 2025, supported by their central role in establishing and maintaining pneumoperitoneum during laparoscopic procedures. Their integration with insufflation devices enables controlled delivery of carbon dioxide and stable operating conditions.
The insufflation tubing sets segment is expected to grow at a CAGR of 6.31% during the forecast period, driven by the use of minimally invasive procedures and the need for reliable gas delivery between insufflation systems and patients. Their single-use design also supports convenient procedure preparation and infection control.
Request Customizationto receive a tailored report.
The laparoscopic surgery segment accounted for a share of 42.6% in 2025, owing to the widespread use of insufflation to create adequate abdominal working space during minimally invasive surgery. The adoption of laparoscopic techniques across multiple procedures supports demand for insufflation devices.
The bariatric surgery segment is expected to grow at a CAGR of 7.15% during the forecast period, fueled by the use of minimally invasive approaches for weight management procedures and the need for consistent abdominal distension during surgery.
The hospitals segment accounted for a share of 61.45% in 2025 due to the high volume of laparoscopic and other minimally invasive procedures performed in hospital operating rooms. Advanced surgical infrastructure and access to specialized teams further support the use of insufflation devices.
The ambulatory surgical center segment is expected to grow at a CAGR of 7.18% during the forecast period, propelled by the shift toward outpatient minimally invasive procedures and the increasing capacity of these facilities to perform short-stay surgeries. Insufflation devices are essential for establishing the surgical field in laparoscopic procedures performed in these settings.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Development of Next-Generation Laparoscopic Systems and Standardized Operator Practices
The North America insufflation devices market accounted for the largest regional share of 39.85% in 2025, supported by the use of CO₂ pressure control systems and increasing demand for insufflation equipment in endoscopic procedures.
The U.S. insufflation devices market is expected to benefit from the development of next-generation laparoscopic systems designed to expand access to minimally invasive surgery. An NIH-funded project running from September 2026 to August 2031 is developing a lower-cost, portable laparoscope targeting a price below USD 1,000, which could support broader deployment of laparoscopic procedures and associated insufflation equipment.
The Canada market is supported by established use of CO₂ insufflation in endoscopic procedures and standardized operator practices. The Canadian Society of Gastroenterology Nurses and Associates recommends competency in operating CO₂ insufflation systems during endoscopic procedures, supporting consistent use of dedicated insufflation equipment.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Fueled by Research on CO₂ Delivery and Procurement of 4K Laparoscopic Surgery Sets
The Asia Pacific insufflation devices market is expected to grow at a CAGR of 7.93% during the forecast period, showcasing the fastest-growing regional growth.
The Japan market is supported by the use of CO₂ delivery in gastrointestinal endoscopy and a robust research ecosystem. For instance, a 2026 Japanese clinical study, registered with Japan’s Ministry of Health, Labour and Welfare, is prospectively comparing total underwater colonoscopy with CO₂ insufflation, directly evaluating the use of CO₂ insufflation during colonoscopic procedures.
China's insufflation devices market is expected to benefit from continued expansion of laparoscopic surgical infrastructure and centralized procurement of advanced minimally invasive equipment. China's public hospitals are procuring laparoscopic endoscopy surgical systems to advance the operating room equipment landscape.
India's insufflation devices market is expected to benefit from the expansion of minimally invasive surgical infrastructure and advanced operating-room capacity. For instance, AIIMS New Delhi initiated procurement of six 4K laparoscopic surgery sets and additional laparoscopic surgical equipment, indicating continued investment in laparoscopic capabilities.
Europe: Market Expansion Led by Centralized Procurement of Surgical Equipment and Innovations in Medical Devices
The Europe insufflation devices market is expected to grow at a CAGR of 5.81% during the forecast period, supported by the use of controlled gas insufflation for CT colonography and cardiac surgical procedures.
The UK insufflation devices market is expected to benefit from continued expansion of minimally invasive surgery and centralized procurement of related surgical equipment. In 2026, NHS Supply Chain launched a new Minimally Invasive Surgery, Related Equipment and Accessories framework running through August 2028, with 60 suppliers providing equipment and accessories for NHS trusts.
Germany's insufflation devices market is expected to benefit from the continued use of minimally invasive and laparoscopic procedures across surgical specialties. Germany's medical technology policy also prioritizes innovation in medical devices, supporting the development and modernization of equipment used in minimally invasive surgery.
Latin America: Market Shaped by Long-Term Modernization of Surgical Infrastructure and Expanding Infrastructure Base for Surgical Equipment Procurment
The Latin America insufflation devices market is expected to grow at a CAGR of 6.38% during the forecast period. Mexico's insufflation devices market is expected to benefit from the planned expansion and modernization of hospital infrastructure, creating additional capacity for minimally invasive surgical services. By 2030, Mexico plans to implement 152 hospital projects and add 9,139 new beds, supported by an estimated investment of USD 10.0 billion, strengthening the infrastructure base for surgical equipment procurement.
Brazil's insufflation devices market is expected to benefit from long-term modernization of surgical infrastructure under Brazil's SUS. The Ministry of Health established a 2026–2031 Medical Equipment Investment Plan to guide procurement and modernization of the SUS equipment base, including equipment used for diagnostic and therapeutic procedures.
Middle East & Africa: Market Shaped by Strict Surgical Procedure Laws and Procurement Priority of Insufflation Equipment
The Middle East & Africa insufflation devices market is expected to grow at a CAGR of 6.72% during the forecast period, due to strict laws for performing laparoscopic surgery and public procurement of dedicated insufflation equipment. The UAE national standards specified that laparoscopic surgery can only be performed in a licensed hospital setting, strengthening demand for the regulatory-approved insufflation systems and related equipment required for these procedures.
South Africa's insufflation devices market is expected to benefit from ongoing efforts to improve the availability and quality of medical equipment across public healthcare facilities. The National Department of Health's 2026–27 annual plan identifies medical equipment availability and procurement as a priority, while the National Treasury's medical equipment contract covers supply, installation, commissioning, training, and maintenance from August 2026 to July 2030.
The insufflation devices market competitive landscape is moderately concentrated, with a mix of multinational medical device manufacturers, minimally invasive surgery specialists, endoscopy equipment companies, laparoscopic technology providers, and regional surgical equipment manufacturers. Key players such as RX Remedial Equipment (OPC) Private Limited, Johnson & Johnson, FUJIFILM Holdings Corporation, Stryker Corporation, and Olympus Corporation are collectively estimated to account for 30–35% of the global insufflation devices market share.
Established participants compete mainly through insufflation pressure control, gas flow accuracy, integration with laparoscopic and endoscopic systems, ease of use, regulatory compliance, and hospital distribution networks. Emerging, niche, and regional companies in the insufflation devices market ecosystem compete through compact equipment, improved safety features, cost-efficient systems, portable designs, and localized service and distribution capabilities.
August 2026: KARL STORZ received FDA clearance for ENDOFLATOR+ with Smart Smoke Evacuation.
June 2026: The FDA cleared Weyo's wAlcor C50 and C35 insufflator series.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Cardiac Resynchronization Therapy (CRT) Market Size, Share, 2034
Automated Microbial Identification Market Size, Share, Growth, 2034
Microsutures Market Size, Share, Growth, Analysis, Report, 2034
Capnography Device Market Size, Share, Growth, Analysis, 2034
Disposable Laparoscopic Instruments Market Size, Share, Growth, 2034
Burn Care Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com